LSE:DXRX

Diaceutics PLC · LSE · Healthcare · GBP · FY for 2025

Figures on this page computed 2026-11-08 12:42 UTC

Last close

n/aGBp

Market data

1822.7xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
GBp
- computed
- Computed from the filing for 2025
0.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
0.3%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
3.7%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
0.03Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
GBp
- computed

Price is the furthest below its sector's middle: 0.16 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

2.18x

1.52x

-0.69x

0.83x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales2.18x
Its own average over 10 years, 17.6M.
Profit1.52x
Its own average over 10 years, 63.7K.
Free cash flow-0.69x
Its own average over 10 years, -2.1M.
Debt0.83x
Its own average over 10 years, 1.4M.
Pricen/a
Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at -0.69 times.

Sales is 2.18 times its own 10-year average; Profit is 1.52 times its own 10-year average; Free cash flow is -0.69 times its own 10-year average; Debt is 0.83 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales against its own 10-year average2.18
Source
computed
Statement
income
Fiscal year
2025
Reported in
GBP
Profit against its own 10-year average1.52
Source
computed
Statement
income
Fiscal year
2025
Reported in
GBP
Free cash flow against its own 10-year average-0.69
Source
computed
Statement
income
Fiscal year
2025
Reported in
GBP
Debt against its own 10-year average0.83
Source
computed
Statement
income
Fiscal year
2025
Reported in
GBP
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
GBp